Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiomics analysis reveals dermokine as a regulator of keratinocyte differentiation and adhesion.

JCI insight·2026
Same author

The Role of Glycan Structures in Modulating GM-CSF Bioactivity: Insights from Glycoengineering.

bioRxiv : the preprint server for biology·2026
Same author

<i>MGAT1</i> knockout in human dendritic cells enhance CD8<sup>+</sup> T cell activation.

Frontiers in immunology·2026
Same author

Meta-inflammation and endotoxemia in a highly translational porcine model of diet-induced obesity.

Lab animal·2025
Same author

Implications of glycosylation for the development of selected cytokines and their derivatives for medical use.

Biotechnology advances·2024
Same author

Chemical synthesis and immunological evaluation of cancer vaccines based on ganglioside antigens and α-galactosylceramide.

RSC medicinal chemistry·2024

Related Experiment Video

Updated: May 9, 2026

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
07:01

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

What makes cancer stem cell markers different?

Uwe Karsten1, Steffen Goletz

  • 1Glycotope GmbH, Robert-Rössle-Str.10, D-13125 Berlin-Buch, Germany.

Springerplus
|July 27, 2013
PubMed
Summary

Cancer stem cell (CSC) targeting faces challenges in distinguishing CSCs from normal stem cells. This study proposes glycosylation as a potential key to differentiating CSC markers from normal stem cell markers.

Keywords:
Cancer stem cellsGlycosylationStem cellsTherapeutic targetsThomsen-Friedenreich antigen

More Related Videos

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Related Experiment Videos

Last Updated: May 9, 2026

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
07:01

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Area of Science:

  • Oncology
  • Stem Cell Biology
  • Biochemistry

Background:

  • The cancer stem cell (CSC) concept is widely accepted, leading to strategies targeting CSCs.
  • Stem cell markers are primary targets for cancer therapies.
  • A key challenge remains distinguishing cancer stem cells from normal stem cells.

Purpose of the Study:

  • To address the challenge of tumor specificity in cancer stem cell therapies.
  • To investigate how cancer stem cell markers differ from normal stem cell markers.
  • To propose a hypothesis for differentiating CSCs from normal stem cells.

Main Methods:

  • Literature review and hypothesis formulation.
  • Analysis of stem cell marker characteristics.
  • Exploration of glycosylation patterns in stem cells.

Main Results:

  • The problem of tumor specificity has shifted to differentiating CSCs from normal stem cells.
  • Glycosylation is hypothesized to be a key factor in this differentiation.
  • This approach may solve the marker differentiation problem for a subgroup of stem cell markers.

Conclusions:

  • Glycosylation offers a potential solution for distinguishing cancer stem cells from normal stem cells.
  • Understanding glycosylation differences can refine CSC-targeted therapies.
  • Further research into glycosylation patterns is warranted for developing specific CSC treatments.